RNA CoMPASS: A dual approach for pathogen and host

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Xu, Guorong ^a   Strong, Michael J ^b   Lacey, Michelle R ^c   Baribault, Carl ^c   Flemington, Erik K ^b   Taylor, Christopher M ^d,e  

^a USA   (United States)

^b TULANE UNIVERSITY   (United States)

^c Tulane University   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; TRANSCRIPTOME; INTERFERON; RNA;

ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CLUSTER ANALYSIS; COMPUTER INTERFACE; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; NONHUMAN; PHENOTYPE; RNA COMPREHENSIVE MULTI PROCESSOR ANALYSIS SYSTEM FOR SEQUENCING; RNA SEQUENCE; SIGNAL TRANSDUCTION; BIOLOGY; CELL LINE; COMPUTER PROGRAM; EPSTEIN BARR VIRUS; GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; PROCEDURES; SEQUENCE ANALYSIS; TUMOR CELL LINE; VIROLOGY;

B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL LINE; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INTERFERONS; NF-KAPPA B; RNA; SEQUENCE ANALYSIS, RNA; SOFTWARE; TRANSCRIPTOME;

EID: 84896090972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089445     Document Type: Article

References (35)

1. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma. Science 319: 1096-1100. (Pubitemid 351300792)
2. Kostic AD, Ojesina AI, Pedamallu CS, Jung J, Verhaak RGW, et al. (2011) PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat Biotech 29: 393-396.
3. Castellarin M, Warren R, Freeman JD, Dreolini L, Krzywinski M, et al. (2011) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Research.
4. Coco JR, EK Flemington, CM Taylor (2011) PARSES: A Pipeline for Analysis of RNA-Seq Exogenous Sequences. Proceedings of the ISCA 3rd International Conference on Bioinformatics and Computational Biology. Holiday Inn Downtown-Superdome, New Orleans, Louisiana, USA 2011: BICoB-2011. pp. 196-200.
5. Weber G, Shendure J, Tanenbaum DM, Church GM, Meyerson M (2002) Identification of foreign gene sequences by transcript filtering against the human genome. Nat Genet 30: 141-142.
6. Moore RA, Warren R, Freeman JD, Gustavsen JA, Chenard C, et al. (2011) The Sensitivity of Massively Parallel Sequencing for Detecting Candidate Infectious Agents Associated with Human Tissue. PLoS ONE 6: e19838.
7. Xu Y, Stange-Thomann N, Weber G, Bo R, Dodge S, et al. (2003) Pathogen discovery from human tissue by sequence-based computational subtraction. Genomics 81: 329-335. (Pubitemid 36349239)
8. Feng H, Taylor JL, Benos PV, Newton R, Waddell K, et al. (2007) Human Transcriptome Subtraction by Using Short Sequence Tags To Search for Tumor Viruses in Conjunctival Carcinoma. Journal of Virology 81: 11332-11340. (Pubitemid 47536104)
9. Westermann AJ, Gorski SA, Vogel J (2012) Dual RNA-seq of pathogen and host. Nat Rev Micro 10: 618-630.
10. Concha M, Wang X, Cao S, Baddoo M, Fewell C, et al. (2012) Identification of New Viral Genes and Transcript Isoforms during Epstein-Barr Virus Reactivation using RNA-Seq. Journal of Virology 86: 1458-1467.
11. Nix D, Courdy S, Boucher K (2008) Empirical methods for controlling false positives and estimating confidence in ChIP-Seq peaks. BMC Bioinformatics 9: 523.
12. Xu G, Deng N, Zhao Z, Judeh T, Flemington E, et al. (2011) SAMMate: a GUI tool for processing short read alignments in SAM/BAM format. Source Code for Biology and Medicine 6: 2.
13. Pruitt KD, Tatusova T, Brown GR, Maglott DR (2012) NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Research 40: D130-D135.
14. Huson DH, Mitra S, Ruscheweyh HJ, Weber N, Schuster SC (2011) Integrative analysis of environmental sequences using MEGAN4. Genome Research 21: 1552-1560.
15. Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
16. Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
17. Deng N, Puetter A, Zhang K, Johnson K, Zhao Z, et al. (2011) Isoform-level microRNA-155 target prediction using RNA-seq. Nucleic Acids Res 39: e61.
18. Nguyen T, Deng N, Xu G, Duan Z, Zhu D (2011) iQuant: A fast yet accurate GUI tool for transcript quantification. Bioinformatics and Biomedicine Workshops (BIBMW), 2011 IEEE International Conference on. pp. 1048-1050.
19. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. Journal of Molecular Biology 215: 403-410.
20. Birol I, Jackman SD, Nielsen CB, Qian JQ, Varhol R, et al. (2009) De novo transcriptome assembly with ABySS. Bioinformatics 25: 2872-2877.
21. Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E (2013) The landscape of viral expression and host gene fusion and adaptation in human cancer. Nature Communications 4.
22. Strong MJ, Xu G, Coco J, Baribault C, Vinay DS, et al. (2013) Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy. PLoS Pathog 9: e1003341.
23. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, et al. (2006) Molecular Diagnosis of Burkitt's Lymphoma. New England Journal of Medicine 354: 2431-2442. (Pubitemid 43855046)
24. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, et al. (2006) A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling. New England Journal of Medicine 354: 2419-2430. (Pubitemid 43855045)
25. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, et al. (2003) A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proceedings of the National Academy of Sciences 100: 8164-8169. (Pubitemid 36842516)
26. Schuhmacher M, Kohlhuber F, Holzel M, Kaiser C, Burtscher H, et al. (2001) The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Research 29: 397-406. (Pubitemid 32060926)
27. Faumont N, Durand-Panteix S, Schlee M, Gromminger S, Schuhmacher M, et al. (2009) c-Myc and Rel/NF-kB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells. Journal of Virology 83: 5014-5027.
28. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nature Reviews Molecular Cell Biology 6: 635-645. (Pubitemid 41081267)
29. Huen D, Henderson S, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10: 549-560.
30. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, et al. (2004) Role of NF-kB in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells. Journal of Virology 78: 4108-4119. (Pubitemid 38437217)
31. Schlee M, Schuhmacher M, Holzel M, Laux G, Bornkamm GW (2007) c-MYC Impairs Immunogenicity of Human B Cells. In: F. V. W George and K George, editors. Advances in Cancer Research. Academic Press. pp. 167-188.
32. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, et al. (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490: 116-120.
33. Burgess DJ, Doles J, Zender L, Xue W, Ma B, et al. (2008) Topoisomerase levels determine chemotherapy response in vitro and in vivo. Proceedings of the National Academy of Sciences 105: 9053-9058.
34. Kwak LW, Halpern J, Olshen RA, Horning SJ (1990) Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. Journal of Clinical Oncology 8: 963-977. (Pubitemid 20200184)
35. Azim HA, Santoro L, Bociek RG, Gandini S, Malek RA (2010) High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis. Annals of Oncology 21: 1064-1071.